These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 17237570

  • 1. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A.
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ, Sempowski GD, McKenna SE, Laskowitz DT, Colton CA, Vitek MP.
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [Abstract] [Full Text] [Related]

  • 3. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Wang Y, Mei Y, Feng D, Xu L.
    J Neurosci Res; 2008 Aug 15; 86(11):2441-9. PubMed ID: 18438925
    [Abstract] [Full Text] [Related]

  • 4. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
    Zagon IS, Rahn KA, Bonneau RH, Turel AP, McLaughlin PJ.
    Brain Res; 2010 Jan 15; 1310():154-61. PubMed ID: 19931226
    [Abstract] [Full Text] [Related]

  • 5. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA, Welsh ME, Carter DE, Karlik SJ.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483
    [Abstract] [Full Text] [Related]

  • 6. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
    Campbell AM, Zagon IS, McLaughlin PJ.
    Brain Res; 2012 Sep 07; 1472():138-48. PubMed ID: 22820301
    [Abstract] [Full Text] [Related]

  • 7. Presence of nerve growth factor and TrkA expression in the SVZ of EAE rats: evidence for a possible functional significance.
    Triaca V, Tirassa P, Aloe L.
    Exp Neurol; 2005 Jan 07; 191(1):53-64. PubMed ID: 15589512
    [Abstract] [Full Text] [Related]

  • 8. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y.
    J Neuroimmunol; 2008 Feb 07; 194(1-2):107-14. PubMed ID: 18207251
    [Abstract] [Full Text] [Related]

  • 9. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF.
    Neuroimmunomodulation; 2008 Feb 07; 15(1):76-83. PubMed ID: 18667803
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of nerve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis.
    Micera A, De Simone R, Aloe L.
    Arch Ital Biol; 1995 Mar 07; 133(2):131-42. PubMed ID: 7625888
    [Abstract] [Full Text] [Related]

  • 11. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.
    Linker RA, Mäurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R.
    Nat Med; 2002 Jun 07; 8(6):620-4. PubMed ID: 12042814
    [Abstract] [Full Text] [Related]

  • 12. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I, Pekovic S, Subasic S, Mostarica-Stojkovic M, Stosic-Grujicic S, Medic-Mijacevic L, Pejanovic V, Rakic L, Stojiljkovic M.
    J Neurosci Res; 2003 Apr 15; 72(2):268-78. PubMed ID: 12672002
    [Abstract] [Full Text] [Related]

  • 13. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis.
    Moore CS, Earl N, Frenette R, Styhler A, Mancini JA, Nicholson DW, Hebb AL, Owens T, Robertson GS.
    J Pharmacol Exp Ther; 2006 Oct 15; 319(1):63-72. PubMed ID: 16809479
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR, Kanwar RK, Krissansen GW.
    Brain; 2004 Jun 15; 127(Pt 6):1313-31. PubMed ID: 15130951
    [Abstract] [Full Text] [Related]

  • 15. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 15; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 16. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
    Zagon IS, Rahn KA, Turel AP, McLaughlin PJ.
    Exp Biol Med (Maywood); 2009 Nov 15; 234(11):1383-92. PubMed ID: 19855075
    [Abstract] [Full Text] [Related]

  • 17. Differential modulatory effect of NGF on MHC class I and class II expression in spinal cord cells of EAE rats.
    Stampachiacchiere B, Aloe L.
    J Neuroimmunol; 2005 Dec 15; 169(1-2):20-30. PubMed ID: 16169604
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin.
    Chen X, Pi R, Zou Y, Liu M, Ma X, Jiang Y, Mao X, Hu X.
    Eur J Pharmacol; 2010 Mar 10; 629(1-3):40-6. PubMed ID: 20006598
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
    Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q.
    J Neuroimmunol; 2009 Jan 03; 206(1-2):58-69. PubMed ID: 19081144
    [Abstract] [Full Text] [Related]

  • 20. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis.
    Brand-Schieber E, Werner P.
    Exp Neurol; 2004 Sep 03; 189(1):5-9. PubMed ID: 15296830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.